- Home
- PMTS vs TERN Comparison
PMTS vs TERN Comparison
Compare PMTS & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- TERN
- Stock Information
- Founded
- PMTS 2007
- TERN 2017
- Country
- PMTS United States
- TERN United States
- Employees
- PMTS N/A
- TERN N/A
- Industry
- PMTS Finance Companies
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- TERN Health Care
- Exchange
- PMTS Nasdaq
- TERN Nasdaq
- Market Cap
- PMTS 341.5M
- TERN 382.2M
- IPO Year
- PMTS 2015
- TERN 2021
- Fundamental
- Price
- PMTS $30.12
- TERN $4.43
- Analyst Decision
- PMTS Strong Buy
- TERN Buy
- Analyst Count
- PMTS 4
- TERN 5
- Target Price
- PMTS $34.00
- TERN $18.30
- AVG Volume (30 Days)
- PMTS 32.8K
- TERN 1.9M
- Earning Date
- PMTS 03-06-2025
- TERN 03-13-2025
- Dividend Yield
- PMTS N/A
- TERN N/A
- EPS Growth
- PMTS N/A
- TERN N/A
- EPS
- PMTS 1.30
- TERN N/A
- Revenue
- PMTS $458,377,000.00
- TERN N/A
- Revenue This Year
- PMTS $9.23
- TERN N/A
- Revenue Next Year
- PMTS $7.51
- TERN N/A
- P/E Ratio
- PMTS $23.11
- TERN N/A
- Revenue Growth
- PMTS N/A
- TERN N/A
- 52 Week Low
- PMTS $15.00
- TERN $4.32
- 52 Week High
- PMTS $35.19
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- PMTS 44.13
- TERN 26.46
- Support Level
- PMTS $28.01
- TERN $4.56
- Resistance Level
- PMTS $31.07
- TERN $5.95
- Average True Range (ATR)
- PMTS 1.55
- TERN 0.29
- MACD
- PMTS -0.29
- TERN -0.10
- Stochastic Oscillator
- PMTS 41.45
- TERN 3.17
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.